Literature DB >> 3796608

An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines.

J Kitajewski, R J Schneider, B Safer, T Shenk.   

Abstract

The VAI RNA of adenovirus is a small, RNA polymerase III-transcribed species required for the efficient translation of host cell and viral mRNAs late after infection. VAI RNA prevented activation of the interferon-induced P1/eIF-2 alpha kinase. In its absence the kinase was activated, eIF-2 alpha was phosphorylated, and translational initiation was inhibited. H5dl331 (dl331), a mutant which cannot express VAI RNA, grew poorly in 293 cells but generated wild-type yields in KB cells. The growth phenotype of the mutant appeared to correlate with the kinetics of kinase induction and activation. Active kinase appeared more rapidly in cell extracts prepared from infected 293 cells, in which dl331 grew poorly, than in extracts of KB cells, in which the mutant grew well. However, when kinase was induced in KB cells by interferon treatment and then activated subsequent to dl331 infection, viral protein synthesis was less severely inhibited than in interferon-treated 293 cells. Thus, activated kinase per se is insufficient to severely inhibit dl331 protein synthesis in KB cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3796608      PMCID: PMC367233          DOI: 10.1128/mcb.6.12.4493-4498.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  Location of sequences on the adenovirus genome coding for the 5.5S RNA.

Authors:  U Pettersson; L Philipson
Journal:  Cell       Date:  1975-09       Impact factor: 41.582

2.  Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis.

Authors:  W K Roberts; A Hovanessian; R E Brown; M J Clemens; I M Kerr
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

3.  Interferon, double-stranded RNA, and protein phosphorylation.

Authors:  B Lebleu; G C Sen; S Shaila; B Cabrer; P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

4.  Factors involved in initiation of haemoglobin synthesis can be phosphorylated in vitro.

Authors:  J A Traugh; S M Tahara; S B Sharp; B Safer; W C Merrick
Journal:  Nature       Date:  1976-09-09       Impact factor: 49.962

5.  Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells.

Authors:  A Zilberstein; P Federman; L Shulman; M Revel
Journal:  FEBS Lett       Date:  1976-09-15       Impact factor: 4.124

6.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

7.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.

Authors:  J Kitajewski; R J Schneider; B Safer; S M Munemitsu; C E Samuel; B Thimmappaya; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

8.  RNA of low molecular weight in KB cells infected with adenovirus type 2.

Authors:  P R Reich; B G Forget; S M Weissman
Journal:  J Mol Biol       Date:  1966-06       Impact factor: 5.469

9.  A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2.

Authors:  H Söderlund; U Pettersson; B Vennström; L Philipson; M B Mathews
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

10.  Genes for VA-RNA in adenovirus 2.

Authors:  M B Mathews
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

View more
  17 in total

1.  Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells.

Authors:  Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 2.  Adenovirus virus-associated RNA and translation control.

Authors:  M B Mathews; T Shenk
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  Sensitivity of subgroup F adenoviruses to interferon.

Authors:  C T Tiemessen; A H Kidd
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor.

Authors:  M V Davies; M Furtado; J W Hershey; B Thimmappaya; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species.

Authors:  B W Hayes; G C Telling; M M Myat; J F Williams; S J Flint
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells.

Authors:  R Petryshyn; J J Chen; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI.

Authors:  M Kostura; M B Mathews
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

8.  Functional dissection of adenovirus VAI RNA.

Authors:  M R Furtado; S Subramanian; R A Bhat; D M Fowlkes; B Safer; B Thimmappaya
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

9.  Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase.

Authors:  S Gunnery; A P Rice; H D Robertson; M B Mathews
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

10.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.